Pillstats
Rx only · Spray, Metered · Nasal

Ipratropium Bromide

Ipratropium Bromide

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US12 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)203212
US makers7 labelers
Packages12
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 10 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.192$0.384$0.576$0.768Dec 2025Apr 2026Jul 2026
$0.589
Latest avg · Jul 22, 2026
-12%
Since Dec 17, 2025
7
Active US suppliers
33%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

35K70K105K140K2025 Q12025 Q22025 Q32025 Q42026 Q1
103K
Rx · 2026 Q1
2.4M
Units dispensed
-16%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Lupin Pharmaceuticals,Inc.unknown2SUPPLYING
Advagen Pharma Ltdunknown2SUPPLYING
Bausch & Lomb Incorporatedunknown2SUPPLYING
NorthStar Rx LLCunknown2SUPPLYING
Apotex Corp.unknown2SUPPLYING
Oceanside Pharmaceuticalsunknown1SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.